JPRN-UMIN000000595未知4 期
A multicenter open-label randomized controlled trial comparing interferon-entecavir sequential therapy with interferon monotherapy for chronic hepatitis B - Interferon-entecavir sequential therapy for chronic hepatitis B: a randomized controlled trial
Department of Gastroenterology and Hepatology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences0 个研究点目标入组 170 人开始时间: 2007年8月1日最近更新:
适应症
试验速览
- 阶段
- 4 期
- 发起方
- 入组人数
- 170
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 25years-old 至 45years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •(1)The patients who have an allergy against interferons (2)The patients who have an allergy against nucleos(t)ide analogues (3)The patients who have received interferon or nucleoside analogue within 6 months before registration (4)Pregnant women, or women who are nursing (5)The patients with an uncontrollable heart trouble (myocardial infarction, heart failure, or arrhythmia) (6)The patients with chronic renal failure, or chronic respiratory failure (7)The patients with a severe mental disease such as depression, a suicide consideration, or a suicide project, or the past history of such conditions (8)The patients with liver cirrhosis or severe hepatic diseases (9)The patients having a past history of cerebral hemorrhage or cerebral infarction (10)The patients with other liver diseases such as autoimmune hepatitis, primary biliary cirrhosis, alcoholic liver injury, or chronic hepatitis C (11)The patients having non-liver autoimmune diseases, such as rheumatoid arthritis (12)The patients who are prescribed with Shoh-saiko-toh (13)The patients who were judged inappropriate for the study by the doctor.
研究者
相似试验
已完成
4 期
A multicenter open-label randomized controlled trial comparing continuing lamivudine treatment with switching from lamivudine to entecavir treatment for the patients with chronic hepatitis B or cirrhosis receiving lamivudine administration without lamivudine-resistant YMDD mutant virus.Chronic hepatitis B or cirrhosisJPRN-UMIN000000601Department of Gastroenterology and Hepatology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences120
已完成
4 期
A multicenter open-label randomized controlled trial comparing interferon-nucleoside/nucleotide analogues add-on therapy with interferon-nucleoside/nucleotide analogues sequential therapy for chronic hepatitis B.chronic hepatitis BJPRN-UMIN000021768Department of Gastroenterology,Saitama Medical Center, Jichi Medical University60
尚未招募
不适用
A randomized multicenter open-label controlled trial to show that mucous fistula refeeding reduces the time from enterostomy closure to full enteral feeds (MUCous FIstula REfeeding (*MUC-FIRE*) trial)Enterostomymucous fistula refeedingNL-OMON56093niversity of Leipzig, Department of Pediatric Surgery16
尚未招募
Unknown
A multi-center open-label randomized controlled trial to evaluate the efficacy of the Mantis Clip for defect closure following colorectal endoscopic submucosal dissectioJPRN-UMIN000054070The Jikei University School of Medicine250
招募中
不适用
Open-label, multicenter, randomized controlled trials, for comparing remission induction rate of a dose-escalation therapy of methotrexate and an additional combination therapy with bucillamine for naive patients to over 8 mg/weekly of methotrexate.Rheumatoid arthritisJPRN-UMIN000007404KONAMON Study Group90